Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
327.40Prev. Close
368.15Volume
0Total traded value
NAUpper Circuit
441.75Lower Circuit
294.55Fundamentals
| Market Cap | ₹441Cr |
| ROE | 3.34% |
| P/E Ratio(TTM) | 60.48 |
| EPS(TTM) | 5.37 |
| P/B Ratio | 1.71 |
| Dividend Yield | 0.29% |
| Industry P/E | 35.31 |
| Book Value | 190.23 |
| Debt to Equity | 0.16 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Medicamen Biotech
Medicamen Biotech is a pharmaceutical leader, producing products for general medicine, pain management, diabetology, cardiology, and now strategically entering oncology. Its vision is to become a preferred pharmaceutical company, achieving leadership in quality, market share, and profit through a high-performance culture. Demonstrating its scale, the company's portfolio includes 100 products with another 40 currently in the pipeline.;
| Parent Organisation | Medicamen Biotech |
| Managing Director | Shri. Bal Gupta |
| NSE Symbol | MEDICAMEQ |
Shareholding Pattern
Dec '24
Mar '25
Apr '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.69 | ||
| Gland Pharma | NA (0.00%) | 41.16 | ||
| Ajanta Pharma | NA (0.00%) | 32.96 | ||
| Eris Lifesciences | NA (0.00%) | 52.58 |